Intravesical chemotherapy synergize with an immune adjuvant by a thermo-sensitive hydrogel system for bladder cancer

Surgical resection remains the prefer option for bladder cancer treatment. However, the effectiveness of surgery is usually limited for the high recurrence rate and poor prognosis. Consequently, intravesical chemotherapy synergize with immunotherapy in situ is an attractive way to improve therapeuti...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, J., Yang, T.Y., Dai, L.Q., Shi, K., Hao, Y., Chu, B.Y., Hu, D.R., Bei, Z.W., Yuan, L.P., Pan, M., Qian, Z.Y.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: KeAi Publishing 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10468327/
https://www.ncbi.nlm.nih.gov/pubmed/37663619
http://dx.doi.org/10.1016/j.bioactmat.2023.08.013

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10468327/
https://www.ncbi.nlm.nih.gov/pubmed/37663619
http://dx.doi.org/10.1016/j.bioactmat.2023.08.013

Ejemplares similares